Company intelligence / Profile preview

Impact Clinical Trials

Los Angeles, California, United Stateslls.org ↗

Ownership: Private
Development stage: Other

Overview

Impact Clinical Trials operates as an experienced and reliable Phase I clinical trial unit. The company focuses on the initial introduction of new drugs into humans, ensuring careful monitoring and protocol adherence. They serve diverse sponsors and patient populations with bilingual staff for improved participant comfort. No specific drug results or programs are disclosed publicly.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Impact Clinical Trials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impact Clinical Trials.

Explore the full profile